Loch T
Klinik für Urologie des Diakonissenkrankenhauses Flensburg, Akademisches Lehrkrankenhaus der Christian Albrechts-Universität Kiel, Marienhölzungsweg 2, 24939, Flensburg.
Urologe A. 2006 Jun;45(6):692, 694-8, 700-1. doi: 10.1007/s00120-006-1089-4.
Today, systematic random biopsies have virtually replaced ultrasound as an imaging tool in the early diagnosis and staging of prostate cancer. Transrectal ultrasonography (TRUS) is now utilized almost only to guide the biopsy needle into the correct anatomical or topographical region of the prostate. Nevertheless, a large number of clinically significant carcinomas are not discovered despite of multiple systematic biopsies. This has led to a dramatic increase in the number of biopsy samples taken, with 6, 10, 12 to 143 being taken during one session depending on the site. Newer modalities and innovative techniques are being investigated in order to accurately identify patients with prostate cancer at different stages of the disease. Innovative ultrasonography techniques may improve the diagnosis and staging of current imaging techniques.
如今，系统随机活检几乎已取代超声，成为前列腺癌早期诊断和分期的成像工具。经直肠超声检查（TRUS）现在几乎仅用于引导活检针进入前列腺的正确解剖或地形区域。然而，尽管进行了多次系统活检，仍有大量具有临床意义的癌未被发现。这导致活检样本数量急剧增加，根据部位不同，一次活检可采集6、10、12至143个样本。为了准确识别处于疾病不同阶段的前列腺癌患者，正在研究更新的模式和创新技术。创新的超声技术可能会改善当前成像技术的诊断和分期。
